Literature DB >> 29721821

Active Safety Surveillance in Africa: Pragmatism and Agility.

Alexander N O Dodoo1,2.   

Abstract

Mesh：

Year:  2018        PMID： 29721821     DOI： 10.1007/s40264-018-0677-8

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  15 in total

Review 1.  Pharmacovigilance in resource-limited countries.

Authors:  Sten Olsson; Shanthi N Pal; Alex Dodoo
Journal:  Expert Rev Clin Pharmacol       Date:  2015-06-03       Impact factor: 5.045

2.  Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria--a double-center prospective study.

Authors:  Thierry Rolling; Tsiri Agbenyega; Saadou Issifou; Ayola Akim Adegnika; Justice Sylverken; Dorothee Spahlinger; Daniel Ansong; Sascha J Z Löhr; Gerd D Burchard; Jürgen May; Benjamin Mordmüller; Sanjeev Krishna; Peter G Kremsner; Jakob P Cramer
Journal:  J Infect Dis       Date:  2013-12-26       Impact factor: 5.226

3.  Implementation of RTS,S/AS01 Malaria Vaccine--The Need for Further Evidence.

Authors:  John Clemens; Vasee Moorthy
Journal:  N Engl J Med       Date:  2016-06-30       Impact factor: 91.245

Review 4.  Specialist Cohort Event Monitoring studies: a new study method for risk management in pharmacovigilance.

Authors:  Deborah Layton; Saad A W Shakir
Journal:  Drug Saf       Date:  2015-02       Impact factor: 5.606

5.  Feasibility and cost of using mobile phones for capturing drug safety information in peri-urban settlement in Ghana: a prospective cohort study of patients with uncomplicated malaria.

Authors:  Vida Ami Kukula; Alexander A N Dodoo; Jonas Akpakli; Solomon A Narh-Bana; Christine Clerk; Alexander Adjei; Elizabeth Awini; Simon Manye; Richard Afedi Nagai; Gabriel Odonkor; Christian Nikoi; Martin Adjuik; Patricia Akweongo; Rita Baiden; Bernhards Ogutu; Fred Binka; Margaret Gyapong
Journal:  Malar J       Date:  2015-10-19       Impact factor: 2.979

6.  Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®.

Authors:  Haggar H Ampadu; Jarno Hoekman; Marieke L de Bruin; Shanthi N Pal; Sten Olsson; Daniele Sartori; Hubert G M Leufkens; Alexander N O Dodoo
Journal:  Drug Saf       Date:  2016-04       Impact factor: 5.606

7.  The Burden of Adverse Drug Reactions Due to Artemisinin-Based Antimalarial Treatment in Selected Ugandan Health Facilities: An Active Follow-Up Study.

Authors:  Helen Byomire Ndagije; Victoria Nambasa; Leonard Manirakiza; Donna Kusemererwa; Dan Kajungu; Sten Olsson; Niko Speybroeck
Journal:  Drug Saf       Date:  2018-08       Impact factor: 5.606

8.  Safety Profile of Artemether-Lumefantrine: A Cohort Event Monitoring Study in Public Health Facilities in Tanzania.

Authors:  Alambo K Mssusa; Adam M Fimbo; Alex F Nkayamba; Henry F Irunde; Hiiti B Sillo; Danstan H Shewiyo; Geraldine Hill; Omary M Minzi
Journal:  Clin Drug Investig       Date:  2016-05       Impact factor: 3.580

9.  Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim(®)) in the treatment of uncomplicated malaria at public health facilities in four African countries.

Authors:  Alexander Adjei; Solomon Narh-Bana; Alberta Amu; Vida Kukula; Richard Afedi Nagai; Seth Owusu-Agyei; Abraham Oduro; Eusebio Macete; Salim Abdulla; Tinto Halidou; Ali Sie; Isaac Osei; Esperance Sevene; Kwaku-Poku Asante; Abdunoor Mulokozi; Guillaume Compaore; Innocent Valea; Martin Adjuik; Rita Baiden; Bernhards Ogutu; Fred Binka; Margaret Gyapong
Journal:  Malar J       Date:  2016-01-27       Impact factor: 2.979

10.  Experiences and Lessons From Implementing Cohort Event Monitoring Programmes for Antimalarials in Four African Countries: Results of a Questionnaire-Based Survey.

Authors:  Comfort Kunak Suku; Geraldine Hill; George Sabblah; Mimi Darko; George Muthuri; Edward Abwao; Jayesh Pandit; Adeline Ijeoma Osakwe; Cassandra Elagbaje; Priscilla Nyambayo; Star Khoza; Alexander N Dodoo; Shanthi Narayan Pal
Journal:  Drug Saf       Date:  2015-11       Impact factor: 5.606
View more
  3 in total

Review 1.  Direct reporting of adverse drug reactions by healthcare consumers in Africa: a narrative review.

Authors:  Halimat Adedeji-Adenola; Manimbulu Nlooto
Journal:  Int J Clin Pharm       Date:  2020-09-09

2.  Challenges and lessons learned from four years of planning and implementing pharmacovigilance enhancement in sub-Saharan Africa.

Authors:  Jens-Ulrich Stegmann; Viviane Jusot; Olga Menang; Gregory Gardiner; Sabino Vesce; Stephanie Volpe; Anderson Ndalama; Felix Adou; Opokua Ofori-Anyinam; Olakunle Oladehin; Yolanda Guerra Mendoza
Journal:  BMC Public Health       Date:  2022-08-17       Impact factor: 4.135

3.  Organizational capacities of national pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences.

Authors:  H Hilda Ampadu; Jarno Hoekman; Daniel Arhinful; Marilyn Amoama-Dapaah; Hubert G M Leufkens; Alex N O Dodoo
Journal:  Global Health       Date:  2018-11-16       Impact factor: 4.185
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.